Gregory Jicha, MD, PhD

Dr. Jicha received his M.D. & Ph.D. degrees at the Albert Einstein College of Medicine as an NIH-funded Medical Scientist Training Program Scholar. He went on to complete his Medical Internship, Neurology Residency, and Behavioral Neurology Fellowship at the Mayo Clinic, Rochester, MN. He is currently a Professor and Vice Chair for Academic Affairs in the Department of Neurology and Associate Director for the Sanders-Brown Center on Aging and the Robert T & Nyles Y McCowan Endowed Chair in Alzheimer’s Research at UK.
His current research interests lie in the areas of preclinical dementia states, mild cognitive impairment, vascular contributions to dementia, and clinical trials of disease modifying therapies for degenerative dementias. He has been continuously funded through numerous extramural grants since his matriculation at UK in 2005.
Dr Jicha serves as the Director of the Clinical Core of the UK, NIH/NIA-funded, Alzheimer’s Disease Center, founder and director of the Rural KY Telemedicine Cognitive Clinic, the principle investigator at UK for the National Alzheimer’s Disease Cooperative Study (ADCS) Group, the Alzheimer’s Clinical Trial Consortium (ACTC), the NIH/NINDS MarkVCID consortium, and chairs the Clinical Task Force and Steering Committee for the NIH/NIA Alzheimer’s Disease Center Program. He has served as Chair of the American Academy of Neurology Geriatric section, and as Chair for the International Alzheimer’s Association Clinical Trials Advancement and Methodology Section. He was a founding member of the International Working Group on AD and the International Society for Frontotemporal Dementia. He was nominated this year as a Member of the National Academy of Medicine.
Financial relationships
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:AbbvieDate added:09/09/2025Date updated:09/09/2025Relationship end date:11/05/2026
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:CassavaDate added:09/09/2025Date updated:09/09/2025Relationship end date:09/11/2026
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Cognition TherapeuticsDate added:09/09/2025Date updated:09/09/2025Relationship end date:09/11/2026
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:EisaiDate added:09/09/2025Date updated:09/09/2025Relationship end date:09/10/2026
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Novo NordiskDate added:09/09/2025Date updated:09/09/2025Relationship end date:09/10/2026
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:VivoryonDate added:09/09/2025Date updated:09/09/2025Relationship end date:09/17/2026
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:MedscapeDate added:09/09/2025Date updated:09/09/2025Relationship end date:09/10/2026
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:IQVIADate added:09/09/2025Date updated:09/09/2025